Clinical Trial Update: A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors [Phase 1]

View source ↗

Summary

Phase I clinical trial update for SSS59 monotherapy in patients with advanced malignant tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SSS59

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: Malignant Tumors | Phase 1 | Status: RECRUITING